What is typical frequency and duration of rituxin and bendamustine treatment for relapsed non-hodgkins lymphoma.?

D1,2 q21d. Bendamustine (treanda) +/- Rituximab is typically given days 1 and 2 every 21 days for non-hodgkin's lymphoma (nhl). The dose and frequency are different in cll. Patients often need dose or cycle duration adjustment based on their prior therapies, age, etc. Ref: http://www.Treanda.Com.